153 related articles for article (PubMed ID: 35505144)
1. Incidence of Second Primary Melanoma in Cutaneous Melanoma Survivors.
Wiener AA; Schumacher JR; Racz JM; Weber SM; Xu YG; Neuman HB
Ann Surg Oncol; 2022 Sep; 29(9):5925-5932. PubMed ID: 35505144
[TBL] [Abstract][Full Text] [Related]
2. Risk and survival of cutaneous melanoma diagnosed subsequent to a previous cancer.
Yang GB; Barnholtz-Sloan JS; Chen Y; Bordeaux JS
Arch Dermatol; 2011 Dec; 147(12):1395-402. PubMed ID: 22184761
[TBL] [Abstract][Full Text] [Related]
3. Increased incidence of second primary melanoma in patients with a previous cutaneous melanoma.
DiFronzo LA; Wanek LA; Elashoff R; Morton DL
Ann Surg Oncol; 1999; 6(7):705-11. PubMed ID: 10560858
[TBL] [Abstract][Full Text] [Related]
4. Distribution of subsequent primary invasive melanomas following a first primary invasive or in situ melanoma Queensland, Australia, 1982-2010.
Youlden DR; Youl PH; Soyer HP; Aitken JF; Baade PD
JAMA Dermatol; 2014 May; 150(5):526-34. PubMed ID: 25093216
[TBL] [Abstract][Full Text] [Related]
5. Risks for noncutaneous second primary malignancy in cutaneous malignant melanoma survivors: an analysis of data from the Surveillance, Epidemiology, and End Results (SEER) program.
Vakharia PP; Kelm RC; Orrell KA; Patel KR; Singam V; Ali Y; Rastogi S; Yousif R; Rangel SM; West DP; Nardone B
Int J Dermatol; 2020 Apr; 59(4):463-468. PubMed ID: 31971260
[TBL] [Abstract][Full Text] [Related]
6. Second Primary Malignancies following a Diagnosis of Conjunctival Melanoma.
Mahjoub H; Loya A; Ayaz T; Weng CY
Curr Eye Res; 2022 Apr; 47(4):634-641. PubMed ID: 34898336
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological comparisons of index and second primary melanomas in paediatric and adult populations.
Jung GW; Weinstock MA
Br J Dermatol; 2012 Oct; 167(4):882-7. PubMed ID: 22716099
[TBL] [Abstract][Full Text] [Related]
8. Risk for second primary cancers among pediatric and young adult melanoma survivors.
Luu Y; Han J; Agarwal A; Elkady N; Jaroonwanichkul S; Gulati N; Gittler J
Pediatr Dermatol; 2024; 41(1):12-15. PubMed ID: 37776000
[TBL] [Abstract][Full Text] [Related]
9. Second primary melanomas: incidence and outcome.
Bower MR; Scoggins CR; Martin RC; Mays MP; Edwards MJ; Reintgen DS; Ross MI; Urist MM; Noyes RD; Sussman JJ; Hagendoorn LJ; Stromberg AJ; McMasters K
Am Surg; 2010 Jul; 76(7):675-81. PubMed ID: 20698369
[TBL] [Abstract][Full Text] [Related]
10. A population-based analysis of risk factors for a second primary cutaneous melanoma among melanoma survivors.
Goggins WB; Tsao H
Cancer; 2003 Feb; 97(3):639-43. PubMed ID: 12548605
[TBL] [Abstract][Full Text] [Related]
11. Patient education and regular surveillance results in earlier diagnosis of second primary melanoma.
Uliasz A; Lebwohl M
Int J Dermatol; 2007 Jun; 46(6):575-7. PubMed ID: 17550554
[TBL] [Abstract][Full Text] [Related]
12. Multiple primary melanomas among 16,570 patients with melanoma diagnosed at Kaiser Permanente Northern California, 1996 to 2011.
Moore MM; Geller AC; Warton EM; Schwalbe J; Asgari MM
J Am Acad Dermatol; 2015 Oct; 73(4):630-6. PubMed ID: 26298295
[TBL] [Abstract][Full Text] [Related]
13. Risk of second primary cutaneous and noncutaneous melanoma after cutaneous melanoma diagnosis: A population-based study.
Beroukhim K; Pourang A; Eisen DB
J Am Acad Dermatol; 2020 Mar; 82(3):683-689. PubMed ID: 31626886
[TBL] [Abstract][Full Text] [Related]
14. Incidence, Risk Factors, and Mortality Associated With Second Malignant Neoplasms Among Survivors of Adolescent and Young Adult Cancer.
Chao C; Bhatia S; Xu L; Cannavale KL; Wong FL; Huang PS; Cooper R; Armenian SH
JAMA Netw Open; 2019 Jun; 2(6):e195536. PubMed ID: 31173129
[TBL] [Abstract][Full Text] [Related]
15. Risk of second primary malignancies in patients with cutaneous melanoma.
Schmid-Wendtner MH; Baumert J; Wendtner CM; Plewig G; Volkenandt M
Br J Dermatol; 2001 Dec; 145(6):981-5. PubMed ID: 11899153
[TBL] [Abstract][Full Text] [Related]
16. Subsequent primary cancers among men and women with in situ and invasive melanoma of the skin.
Balamurugan A; Rees JR; Kosary C; Rim SH; Li J; Stewart SL
J Am Acad Dermatol; 2011 Nov; 65(5 Suppl 1):S69-77. PubMed ID: 22018070
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous T-cell lymphoma is associated with increased risk of lymphoma, melanoma, lung cancer, and bladder cancer.
Goyal A; O'Leary D; Goyal K; Patel K; Pearson D; Janakiram M
J Am Acad Dermatol; 2021 Dec; 85(6):1418-1428. PubMed ID: 32822803
[TBL] [Abstract][Full Text] [Related]
18. Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma.
Lam CJ; Curtis RE; Dores GM; Engels EA; Caporaso NE; Polliack A; Warren JL; Young HA; Levine PH; Elmi AF; Fraumeni JF; Tucker MA; Morton LM
J Clin Oncol; 2015 Oct; 33(28):3096-104. PubMed ID: 26240221
[TBL] [Abstract][Full Text] [Related]
19. Epidemiological analysis of second primary malignant neoplasms in cancer survivors aged 85 years and older: a SEER data analysis (1975-2016).
Zhao X; Zhang L; Bai L; Zhao Y; Yang Q
Sci Rep; 2022 Jul; 12(1):11688. PubMed ID: 35803964
[TBL] [Abstract][Full Text] [Related]
20. Earlier diagnosis of second primary melanoma confirms the benefits of patient education and routine postoperative follow-up.
DiFronzo LA; Wanek LA; Morton DL
Cancer; 2001 Apr; 91(8):1520-4. PubMed ID: 11301400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]